Markets:

Overview

News

Currencies

International

Treasuries

Matinas Biopharma Holdings, Inc. Common Stock (NY:MTNB)

0.8300 -0.0400 (-4.60%)

Streaming Delayed Price Updated: 10:04 AM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Matinas Biopharma Holdings, Inc. Common Stock

< Previous 1 2 3 4 Next >

Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 11, 2023

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 11, 2023

Via Benzinga

Recap: Matinas BioPharma Hldgs Q1 Earnings ↗

May 10, 2023

Via Benzinga

Earnings Outlook For Matinas BioPharma Hldgs ↗

March 14, 2023

Via Benzinga

Matinas BioPharma: Q2 Earnings Insights ↗

August 11, 2022

Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:15 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Why Matinas BioPharma Stock Is Sinking Today ↗

May 11, 2023

BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have ended an mRNA-based collaboration.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 11, 2023

Via Benzinga

Why Muscle Maker Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket ↗

May 11, 2023

Gainers Audacy, Inc. (NYSE: AUD) gained 75.8% to $0.2337 in pre-market trading after gaining around 16% on Wednesday. The company posted upbeat quarterly sales.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 11, 2023

It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 10, 2023

Via Benzinga

7 Small-Cap Biotech Stocks with Massive Potential ↗

April 27, 2023

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 14, 2023

Via Benzinga

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 09, 2023

Via Benzinga

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Matinas BioPharma Hldgs: Q1 Earnings Insights ↗

May 12, 2022

Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Preview Of Matinas BioPharma Hldgs's Earnings ↗

May 11, 2022

Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

HC Wainwright Reiterates Buy Rating On BioNTech, While Lowers Price Target ↗

April 12, 2022

HC Wainwright has reiterated its Buy rating on BioNTech SE (NASDAQ: BNTX) while reducing the price tar

Via Benzinga

BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines ↗

April 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech ↗

April 11, 2022

BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have

Via Benzinga

Here's Why Matinas BioPharma Shares Are Rising ↗

April 11, 2022

Matinas BioPharma Holdings Inc (NASDAQ: MTNB) shares are trading higher by 10.4% at $0.86 after the company and BioNTech announced an exclusive research collaboration to...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 25, 2022

Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday!

Via InvestorPlace

34 Stocks Moving in Friday's Pre-Market Session ↗

March 25, 2022

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...

Via Benzinga

Matinas BioPharma Updates — Q4 2021 Earnings And Conference Call Recap ↗

March 21, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Matinas BioPharma: Q4 Earnings Insights ↗

March 08, 2022

Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement....

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.